BRÈVE

sur PharmaLink

PharmaLink Inc. and Recall Results, Inc. Forge Strategic Partnership to Boost Drug Safety and Recall Efficiency

PharmaLink Inc., a leader in pharmaceutical reverse distribution, has teamed up with Recall Results, an expert in recall management, to enhance drug safety and recall efficiency. This alliance brings together PharmaLink’s experience in pharmaceutical returns and Recall Results' advanced recall management technologies.

The partnership aims to develop systems that streamline the recall process, ensuring it is efficient, accurate, and meets public health needs. This collaboration will also focus on direct patient-level support during recalls, enhancing the responsiveness to any health risks posed by pharmaceutical products on the market.

Both companies emphasize their commitment to patient safety and compliance, intending to set new standards in recall efficiency and pharmaceutical care. PharmaLink’s CEO, Thierry Beckers, expressed excitement over the partnership's potential to significantly uplift safety standards within the industry. Similarly, John McFerron, CEO of Recall Results, highlighted the combined expertise that will drive innovations in pharmaceutical safety.

This strategic initiative is anticipated to establish new benchmarks in drug recall management and safety practices, with further details on specific programs to be announced soon.

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de PharmaLink